Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Vorinostat
Vorinostat
149647-78-9
|
264.147
|
0.989
Vorinostat is a histone deacetylase inhibitor used for the treatment of cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma following prior systemic therapies.
N-Hydroxy-N′-phenyloctanediamide | N-hydroxy-N'-phenyloctanediamide | N-hydroxy-N’-phenyl-octanediamide | N1-hydroxy-N8-phenyloctanediamide | SML0061 | Zolinza | saha | suberanilohydroxamic acid | suberanoylhydroxamic acid | suberoylanilide hydroxamic acid | vorinistat | vorinostat
Vorinostat is a histone deacetylase inhibitor used for the treatment of cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma following prior systemic therapies.
N-Hydroxy-N′-phenyloctanediamide | N-hydroxy-N'-phenyloctanediamide | N-hydroxy-N’-phenyl-octanediamide | N1-hydroxy-N8-phenyloctanediamide | SML0061 | Zolinza | saha | suberanilohydroxamic acid | suberanoylhydroxamic acid | suberoylanilide hydroxamic acid | vorinistat | vorinostat
$19/5 mg
(EBC)
1
We provide 0 compound for Vorinostat